Tag Archives: natco

AN UPDATE: India – Natco – Compulsory license

This is an update of Natco’s compulsory license application for Sorafenib and continuation of the earlier post. Controller of patent posted this CL opposition hearing on Jan 06, 2012. (DNA article). Bayer/patentee has sought for adjournment of this hearing (copy of … Continue reading

Posted in Daily interesting IP news, Patent case | Tagged , , , | Leave a comment

Bayer Vs Controller of patents

[SpicyIP] [Order] Yesterday, a interesting news is posted in SpicyIP blog.  Bayer challenges ambiguity in statutory language of “prima facie case” of section 87(1). Controller has published Natco’s compulsory license as per section 87(1) as prima facie case made out (published on Aug 12th … Continue reading

Posted in Daily interesting IP news, Patent case | Tagged , , , | 1 Comment

Natco Gilead Tamiflu ANDA

Today Natco confirmed the first to file status in press release and will have 180 days exclusivity if Natco ANDA approved by FDA. Natco ties up with Alvogen for marketing generic version in USA. As of now, Gilead has not sued … Continue reading

Posted in Patent case | Tagged , , , | 1 Comment